Literature DB >> 3464972

Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin).

M Chignard, M A Selak, J B Smith.   

Abstract

Human neutrophils and platelets were loaded with the intracellular calcium indicator fura-2. The chemotactic peptide N-formyl-Met-Leu-Phe (fMet-Leu-Phe) induced a rapid elevation of cytosolic free calcium in cytochalasin B-treated neutrophils but failed to increase the cytosolic calcium in platelets. On the other hand, when unloaded neutrophils were incubated together with autologous fura-2-loaded platelets, fMet-Leu-Phe stimulated a 6-fold increase in platelet cytosolic calcium subsequent to a brief lag. Parallel experiments demonstrated that the addition of fMet-Leu-Phe to neutrophil/platelet incubates also elicited platelet aggregation and serotonin release. Platelet activation showed a positive correlation with the concentration of fMet-Leu-Phe added to the mixed cell population. Cell-free supernatants prepared from fMet-Leu-Phe-stimulated neutrophils were capable of inducing platelet calcium mobilization, aggregation, and secretion. The amount of platelet-activating material present in the supernatant was proportional to the number of activated neutrophils. Preincubation of platelets with BN 52021, acetylsalicylic acid, SQ-29,548, or hirudin did not modify the aggregation response induced by the supernatant collected from fMet-Leu-Phe-activated neutrophils, suggesting that the material was not 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether), arachidonic acid, thromboxane A2, or thrombin. Pretreatment of the neutrophil supernatant with an ADP (creatine phosphate/creatine phosphokinase) or a superoxide/peroxide (superoxide dismutase/catalase) scavenging system also had no effect on aggregation or secretion, indicating that these substances did not participate in platelet activation. The biological activity present in the neutrophil supernatant was destroyed by heat and inactivated by treatment with phenylmethylsulfonyl fluoride, indicating that it is a protein and most probably an enzyme with serine protease activity. These data provide the direct observation of secondary signal transmission to platelets following primary activation of neutrophils. We propose the name neutrophilin for the neutrophil-derived mediator.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3464972      PMCID: PMC386980          DOI: 10.1073/pnas.83.22.8609

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  PLATELET SEQUESTRATION IN MAN. I. METHODS.

Authors:  R H ASTER; J H JANDL
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  [The reaction between hirudin and thrombin].

Authors:  F MARKWARDT; P WALSMANN
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1958

3.  Oxygen-dependent microbial killing by phagocytes (second of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-30       Impact factor: 91.245

4.  Oxygen-dependent microbial killing by phagocytes (first of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-23       Impact factor: 91.245

5.  Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro.

Authors:  A J Marcus; M J Broekman; L B Safier; H L Ullman; N Islam; C N Sherhan; L E Rutherford; H M Korchak; G Weissmann
Journal:  Biochem Biophys Res Commun       Date:  1982-11-16       Impact factor: 3.575

Review 6.  Release of inflammatory mediators from stimulated neutrophils.

Authors:  G Weissmann; J E Smolen; H M Korchak
Journal:  N Engl J Med       Date:  1980-07-03       Impact factor: 91.245

7.  Human neutrophil-derived platelet activating factor.

Authors:  G Z Lotner; J M Lynch; S J Betz; P M Henson
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

8.  Pulmonary injury induced by C3a and C5a anaphylatoxins.

Authors:  N P Stimler; T E Hugli; C M Bloor
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

9.  Platelet-leukocyte interactions following arterial endothelial injury.

Authors:  N B Ratliff; J M Gerrard; J G White
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

10.  Thromboxane generation by human peripheral blood polymorphonuclear leukocytes.

Authors:  I M Goldstein; C L Malmsten; H Kindahl; H B Kaplan; O Rådmark; B Samuelsson; G Weissmann
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

View more
  15 in total

1.  Platelet-derived growth factor stimulates phagocytosis and blocks agonist-induced activation of the neutrophil oxidative burst: a possible cellular mechanism to protect against oxygen radical damage.

Authors:  E Wilson; S M Laster; L R Gooding; J D Lambeth
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 2.  Bidirectional modulation of platelet and polymorphonuclear leukocyte activities.

Authors:  A Del Maschio; E Dejana; G Bazzoni
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

3.  Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils.

Authors:  E Coëffier; D Joseph; M C Prévost; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

4.  Cathepsin G and thrombin: evidence for two different platelet receptors.

Authors:  M A Selak
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

5.  Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.

Authors:  F Pons; A G Rossi; K E Norman; T J Williams; S Nourshargh
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

6.  Human recombinant platelet phospholipase A2 exacerbates poly-L-arginine induced rat paw edema.

Authors:  G Cirino; C Cicala; L Sorrentino
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

7.  Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.

Authors:  M Hirafuji; H Shinoda
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

8.  Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.

Authors:  P Renesto; V Balloy; T Kamimura; K Masuda; A Imaizumi; M Chignard
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

9.  Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine.

Authors:  P Renesto; V Balloy; B B Vargaftig; M Chignard
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

10.  Intracellular Ca2+ rise in human platelets induced by polymorphonuclear-leucocyte-derived cathepsin G.

Authors:  M Molino; M Di Lallo; G de Gaetano; C Cerletti
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.